Development of a STEAP1-targeted prostate cancer specific antibody drug conjugate platform with immunostimulatory properties
Journal articles
Wang, JS; Sodhi, SS; Tsao, L-C; Lin, GH; Moon, N; Zhang, Q; Liu, B; Tu, VY; Penaranda, J; Trotter, TN; Somarelli, JA; Armstrong, AJ; Wang, G ...
Published in: Journal of Translational Medicine
September 8, 2026
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Journal of Translational Medicine
DOI
EISSN
1479-5876
Publication Date
September 8, 2026
Publisher
Springer Science and Business Media LLC
Related Subject Headings
- Immunology
- 42 Health sciences
- 32 Biomedical and clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Wang, J. S., Sodhi, S. S., Tsao, L.-C., Lin, G. H., Moon, N., Zhang, Q., … Hartman, Z. C. (2026). Development of a STEAP1-targeted prostate cancer specific antibody drug conjugate platform with immunostimulatory properties. Journal of Translational Medicine. https://doi.org/10.1186/s12967-026-08927-z
Wang, John S., Sirajbir S. Sodhi, Li-Chung Tsao, Guang Han Lin, Nicole Moon, Qiang Zhang, Bushangqing Liu, et al. “Development of a STEAP1-targeted prostate cancer specific antibody drug conjugate platform with immunostimulatory properties.” Journal of Translational Medicine, September 8, 2026. https://doi.org/10.1186/s12967-026-08927-z.
Wang JS, Sodhi SS, Tsao L-C, Lin GH, Moon N, Zhang Q, et al. Development of a STEAP1-targeted prostate cancer specific antibody drug conjugate platform with immunostimulatory properties. Journal of Translational Medicine. 2026 Sep 8;
Wang, John S., et al. “Development of a STEAP1-targeted prostate cancer specific antibody drug conjugate platform with immunostimulatory properties.” Journal of Translational Medicine, Springer Science and Business Media LLC, Sept. 2026. Crossref, doi:10.1186/s12967-026-08927-z.
Wang JS, Sodhi SS, Tsao L-C, Lin GH, Moon N, Zhang Q, Liu B, Tu VY, Penaranda J, Trotter TN, Somarelli JA, Armstrong AJ, Lyerly HK, Wang G, Hartman ZC. Development of a STEAP1-targeted prostate cancer specific antibody drug conjugate platform with immunostimulatory properties. Journal of Translational Medicine. Springer Science and Business Media LLC; 2026 Sep 8;
Published In
Journal of Translational Medicine
DOI
EISSN
1479-5876
Publication Date
September 8, 2026
Publisher
Springer Science and Business Media LLC
Related Subject Headings
- Immunology
- 42 Health sciences
- 32 Biomedical and clinical sciences